ATE395002T1 - Verfahren zum verbessern der anhäufung von radioaktiven verbindungen in gewebe - Google Patents

Verfahren zum verbessern der anhäufung von radioaktiven verbindungen in gewebe

Info

Publication number
ATE395002T1
ATE395002T1 AT98966733T AT98966733T ATE395002T1 AT E395002 T1 ATE395002 T1 AT E395002T1 AT 98966733 T AT98966733 T AT 98966733T AT 98966733 T AT98966733 T AT 98966733T AT E395002 T1 ATE395002 T1 AT E395002T1
Authority
AT
Austria
Prior art keywords
compound
radiolabeled compound
radioligand
administration
life
Prior art date
Application number
AT98966733T
Other languages
English (en)
Inventor
Eugene Woltering
Gregory Espenan
Original Assignee
Univ Louisiana State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Louisiana State filed Critical Univ Louisiana State
Application granted granted Critical
Publication of ATE395002T1 publication Critical patent/ATE395002T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/121—Solutions, i.e. homogeneous liquid formulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measurement Of Radiation (AREA)
AT98966733T 1997-11-24 1998-11-23 Verfahren zum verbessern der anhäufung von radioaktiven verbindungen in gewebe ATE395002T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US97752097A 1997-11-24 1997-11-24

Publications (1)

Publication Number Publication Date
ATE395002T1 true ATE395002T1 (de) 2008-05-15

Family

ID=25525221

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98966733T ATE395002T1 (de) 1997-11-24 1998-11-23 Verfahren zum verbessern der anhäufung von radioaktiven verbindungen in gewebe

Country Status (10)

Country Link
EP (1) EP0961591B1 (de)
JP (1) JP2001513114A (de)
CN (1) CN1250361A (de)
AT (1) ATE395002T1 (de)
AU (1) AU749403B2 (de)
CA (1) CA2277180C (de)
DE (1) DE69839477D1 (de)
ES (1) ES2307325T3 (de)
NZ (1) NZ336727A (de)
WO (1) WO1999026551A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2352578C2 (ru) 2001-03-06 2009-04-20 Иль Консорцио Феррара Ричерке Способ модуляции пролиферации клеток медуллярной карциномы щитовидной железы
CN104491890A (zh) * 2014-11-21 2015-04-08 北京肿瘤医院 放射性核素标记的新型生长抑素类似物分子探针及其应用
JP2021506886A (ja) * 2017-12-22 2021-02-22 コーネル ユニバーシティー Ｐｅｔおよびチェレンコフ発光画像化に有用な１８ｆ標識ペプチドリガンド

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9111199D0 (en) * 1991-05-23 1991-07-17 Sandoz Ltd Improvements in or relating to organic compounds
WO1991001144A1 (en) * 1989-07-20 1991-02-07 Sandoz Ltd Labeled polypeptide derivatives
SK2094A3 (en) * 1993-01-12 1995-01-12 Sandoz Ag Somatostatine polypeptides, method of their preparing and using
US5597894A (en) * 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
US6358491B1 (en) * 1999-08-27 2002-03-19 Berlex Laboratories, Inc. Somatostatin analogs

Also Published As

Publication number Publication date
EP0961591A4 (de) 2002-07-31
NZ336727A (en) 2001-10-26
CN1250361A (zh) 2000-04-12
JP2001513114A (ja) 2001-08-28
EP0961591A1 (de) 1999-12-08
AU749403B2 (en) 2002-06-27
AU2448499A (en) 1999-06-15
EP0961591B1 (de) 2008-05-14
CA2277180A1 (en) 1999-06-03
WO1999026551A1 (en) 1999-06-03
ES2307325T3 (es) 2008-11-16
CA2277180C (en) 2006-12-05
DE69839477D1 (de) 2008-06-26

Similar Documents

Publication Publication Date Title
Wessels et al. Radionuclide selection and model absorbed dose calculations for radiolabeled tumor associated antibodies
Palmedo et al. Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases
AT392004B (de) Verfahren zur herstellung eines monoklonalen antikoerpers gegen tumor-assoziiertes antigen und dessen verwendung
CA2034484C (en) Radioimmunotherapy using .alpha.-particles emission
HK1107283A1 (en) Method and device for radiotherapy
Dahle et al. Initial evaluation of 227Th-p-benzyl-DOTA-rituximab for low-dose rate α-particle radioimmunotherapy
DE69635080D1 (de) Radiometall-bindende analoge von lhrh
Su et al. Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator
ATE395002T1 (de) Verfahren zum verbessern der anhäufung von radioaktiven verbindungen in gewebe
DK0827411T3 (da) Fremgangsmåde til fastlæggelse af den optimale stråledosis til radiofamaceutisk sygdomsbehandling
Anderson et al. Antibodies labeled with 199Au: Potential of 199Au for radioimmunotherapy
Bernhardt et al. Effects of treatment with 177Lu-DOTA-Tyr3-octreotate on uptake of subsequent injection in carcinoid-bearing nude mice
Zimmerman et al. Enhancing Antibody: III. Site of Activity
Barth et al. Organ distribution of technetium-99m-labeled Corynebacterium parvum in normal and tumor-bearing mice
Mirzadeh et al. Burn-up cross-section of 188W
Tenhunen Physical and biological targeting of radiotherapy
Matzku et al. Antibody targeting to the murine lymphoma ESb‐MP: Increased accumulation due to reduced internauzation into lymphoma cells as compared to normal lymphoid cells
Kwa et al. Radioimmunotherapy of small-cell lung cancer xenografts using 131 I-labelled anti-NCAM monoclonal antibody 123C3
Vallabhajosula Radiopharmaceuticals for therapy
Slosman et al. Use of radioactive ion beams for bio-medical research
Andersson et al. Programme for BNCT with accelerator-produced keV neutrons and related chemical and biological studies
Vaughan et al. Antibodies and isotopes, a chemical approach to tumour targeting
Agha et al. A new technetium-99m-EDTA complex production technique for renal studies
Ehrhardt et al. Radioisotope radiotherapy research and achievements at the University of Missouri Research Reactor
Hazra et al. Radiobioconjugate therapy: Silver and gold as candidate radionuclides-concepts and achievements

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties